Market Scope identified 21 ophthalmic transactions totaling nearly $1.2 billion during Q2-2021. This compares with $2.3 billion from 32 transactions in Q1-2021 and $2.3 billion from 28 transactions in Q2-2020. Funds raised included investments for the development of new products and technologies, commercialization of new products, or outright purchases of products or technologies. Transactions have ranged from $250 thousand to …
Eyenuk Raises $6.2 Million to Boost its EyeArt AI System to Screen for DR
Eyenuk, of Los Angeles, announced July 20 that it had completed a financing round of $6.2 million led by investment management company AXA IM, through AXA IM Alts, with existing investors also participating.
Ocular Therapeutix, Mosaic Biosciences Collaborate on New Targets for Dry AMD
Ocular Therapeutix has entered into a discovery collaboration with Mosaic Biosciences, of Boulder, Colorado, to identify new targets and therapeutic agents aimed at the treatment of dry age-related macular degeneration (AMD).
OIS European Showcase 2021
We are thrilled to be co-hosting the OIS European Showcase once again this year and we’re looking forward to another fantastic event! An exciting lineup of innovative companies is already taking shape for the showcase, which will be followed by a panel discussion with top industry leaders as they focus on how to win in the European market. Join us …
